Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Karyopharm Therapeutics Inc. buy BiotechBee

Karyopharm Therapeutics Inc.
Start price
€1.38
20.07.23 / 60%
Target price
€3.00
20.07.24
Performance (%)
-41.97%
End price
€0.80
10.07.24
Summary
This prediction ended on 10.07.24 with a price of €0.80. Massive losses of -41.97% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Karyopharm Therapeutics Inc. - - - -
iShares Core DAX® 0,18 % 5,07 % 8,98 % 63,88 %
iShares Nasdaq 100 -0,77 % -2,08 % 26,44 % 88,09 %
iShares Nikkei 225® 0,73 % -3,35 % 47,89 % 78,01 %
iShares S&P 500 -0,17 % 0,90 % 22,97 % 69,45 %

According to BiotechBee what are the pros and cons of Karyopharm Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Karyopharm Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -41.97%
Target price 3.000
Change
Ends at 20.07.24

Buy mit Kursziel 3,0

BiotechBee 
0
Report Share
20.07.23
In the thread Trading Karyopharm Therapeutics Inc.
Prediction Buy
Perf. (%) -41.97%
Target price 3.000
Change
Ends at 20.07.24

Buy beendet

BiotechBee 
0
Report Share
10.07.24